Browsing by Author "Sezer, Ahmet"
Now showing items 1-7 of 7
-
An old enemy not to be forgotten during PET CT scanning of cancer patients: tuberculosis
Sumbul, Ahmet Taner; Sezer, Ahmet; Abali, Huseyin; Gultepe, BİLGE; Kocer, Emrah; Reyhan, Mehmet; Tonyali, Onder; Ozyilkan, Ozgur (2016-01-01)Aim of the study: Positron emission tomography-computed tomography (PET CT) scan is commonly used in current medical oncology practice as an imaging method. In this study we present data from cancer patients who were ... -
Cemiplimab monotherapy as first-line (1L) treatment of patients with brain metastases from advanced non-small cell lung cancer (NSCLC) with programmed cell death-ligand 1 (PD-L1) >= 50%: EMPOWER-Lung 1 subgroup analysis.
Gladkov, Oleg; Rietschel, Petra; Gullo, Giuseppe; Bentsion, Dmitry; Clingan, Philip R.; Lowy, Israel; Seebach, Frank A.; Lee, Sue; Pouliot, Jean-Francois; McGinniss, Jennifer; Rizvi, Naiyer A.; Sriuranpong, Virote; Ozguroglu, Mustafa; Sezer, Ahmet; Kilickap, Saadettin; Gumus, Mahmut; Bondarenko, Igor; Gogishvili, Miranda; Turk, Haci M.; Cicin, Irfan (2021-05-01) -
Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial.
Sezer, Ahmet; Kilickap, Saadettin; Gümüş, Mahmut; Bondarenko, Igor; Özgüroğlu, Mustafa; Gogishvili, Miranda; Turk, HACI MEHMET; Cicin, Irfan; Bentsion, Dmitry; Gladkov, Oleg; Clingan, Philip; Sriuranpong, Virote; Rizvi, Naiyer; Gao, Bo; Li, Siyu; Lee, Sue; McGuire, Kristina; Chen, Chieh-I; Makharadze, Tamta; Paydas, Semra; Nechaeva, Marina; Seebach, Frank; Weinreich, David M; Yancopoulos, George D; Gullo, Giuseppe; Lowy, Israel; Rietschel, Petra (2021-02-13) -
Low serum levels of vitamin D in metastatic cancer patients: a case-control study
Sumbul, Ahmet Taner; Sezer, Ahmet; Kavvasoglu, Gamze; Batmaci, Celal Yucel; YENGİL, ERHAN; Yagiz, Abdullah Erman; Gultepe, Ihami; Abali, Huseyin; Ustun, Ihsan; Gokce, Cumali (2014-03-01)Accompanying comorbidities observed during the cancer treatment usually affect the course and outcome of the therapy. Hypovitaminosis D, which is one of these conditions, is a resolvable problem, if recognized. In this ... -
Neutrophil-to-lymphocyte ratio predicts PSA response, but not outcomes in patients with castration-resistant prostate cancer treated with docetaxel
Sumbul, Ahmet Taner; ÖZYILKAN, ÖZGÜR; Sezer, Ahmet; Abali, Huseyin; Kose, Fatih; Gultepe, Ilhami; Mertsoylu, Huseyin; Muallaoglu, Sadik (2014-08-01)The neutrophil-to-lymphocyte ratio (NLR) is a marker of systemic inflammatory response and evidences for the relationship between NLR and the response to treatment gradually increases in cancer patients. In this study, we ... -
Patient-reported symptoms, functioning, and quality of life (QoL) in patients treated with cemiplimab monotherapy for first-line treatment of advanced NSCLC with PD-L1 >= 50%: Results from EMPOWER-Lung 1 study.
Gumus, Mahmut; Mastey, Vera; Harnett, James; Sezer, Ahmet; Chen, Chieh-I; Cicin, Irfan; Turk, Haci M.; Gogishvili, Miranda; Ozguroglu, Mustafa; Bondarenko, Igor; Kilickap, Saadettin; Ivanescu, Cristina; Naumann, Ulrike; Reaney, Matthew; Konidaris, Gerasimos; Sasane, Medha; Brady, Keri; Li, Siyu; Gullo, Giuseppe; Rietschel, Petra (2021-05-01) -
Prognostic value of procalcitonin in infection-related mortality of cancer patients
Sedef, Ali Murat; Kose, Fatih; Sumbul, Ahmet Taner; Dogan, Ozlem; Kursun, Ebru; Yurdakul, Zafer; Gultepe, BİLGE; Mertsoylu, Huseyin; Sezer, Ahmet; Ozyilkan, Ozgur (2016-05-01)Purpose: Infectious diseases are a major cause of morbidity and mortality in cancer patients. Tumor-induced inflammatory responses may increase the value of classical inflammatory markers in blood, so these markers may not ...
